A randomized phase II study of three fludarbine/antibody combinations for patients with symptomatic previously untreated chronic lymphocytic leukemia

Trial Profile

A randomized phase II study of three fludarbine/antibody combinations for patients with symptomatic previously untreated chronic lymphocytic leukemia

Planning
Phase of Trial: Phase II

Latest Information Update: 04 Oct 2007

At a glance

  • Drugs Antibodies; Fludarabine
  • Indications Chronic lymphocytic leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top